Opinion|Videos|October 14, 2024
Takeaways from the UH CINEMA Program
Key Takeaways
- UH CINEMA addresses the complex needs of patients with overlapping cardiovascular, renal, and metabolic conditions through integrated care models.
- Implementation challenges include coordinating multidisciplinary teams and managing resource allocation effectively.
A panel of cardiometabolic risk management experts analyzes key takeaways from the UH CINEMA Program.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Let’s discuss some initiatives we have championed at our institutions. What are these initiatives and how are they impacting the care of CRM patients? Dr. Neeland: Tell us about the University Hospitals Heart & Vascular Institute’s Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (UH CINEMA).
- How is the UH CINEMA program advancing health care for patients with overlapping heart, diabetes, and kidney issues?
- What challenges have you experienced implementing this program?
- What specific results can you share from this program?
- What are future opportunities to improve CRM care based on this program?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Advertisement
Related to this article
These phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.
At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.
AI quantitative CT (UCLA QILD, Brainomix e-Lung) predicts FVC decline and drug response in PPF, strengthening biomarkers beyond spirometry in INBUILD.
The conference session featured updates on several clinical trials, including the BRUNELLO trial, for treatment of diabetic macular edema (DME).
Panelists engaged in a debate regarding using complement inhibitors in geographic atrophy, gauging public sentiment with a deciding vote.
A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help patients receive peak care.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
Advertisement
Advertisement
Trending on AJMC
1
CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care
2
Oral JAK Inhibitors Boost Hair Regrowth Odds in Alopecia Areata
3
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
4
Panel Calls for Earlier Detection, Clearer Pathways in Rare Glomerular Disease
5